首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Safety and efficacy of semaglutide once weekly vs sitagliptin once daily both as monotherapy in Japanese people with type 2 diabetes

【2h】

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily both as monotherapy in Japanese people with type 2 diabetes

机译：在日本2型糖尿病患者中塞马鲁肽与西他列汀每周一次相比西格列汀每天一次的安全性和有效性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsTo assess the safety and efficacy of monotherapy with once‐weekly subcutaneous (s.c.) semaglutide vs sitagliptin in Japanese people with type 2 diabetes (T2D).

机译：目的评估日本2型糖尿病（T2D）患者每周一次皮下注射semaglutide与西他列汀的单药治疗的安全性和有效性。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Yutaka Seino; Yasuo Terauchi; Takeshi Osonoi; Daisuke Yabe; Nobuyuki Abe; Tomoyuki Nishida; Jeppe Zacho; Shizuka Kaneko;
展开▼
作者单位

展开▼
年(卷),期 -1(20),2
年度 -1
页码 378–388
总页数 11
原文格式 PDF
正文语种
中图分类
关键词
GLP‐1 sitagliptin type 2 diabetes;

机译：GLP-1;西他列汀;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in J J apanese people with type 2 diabetes [J] . Seino Yutaka, Terauchi Yasuo, Osonoi Takeshi, Diabetes, obesity & metabolism . 2018,第2期

机译：半蛋白质的安全性和疗效每天vs SitaGliptin每天一次，无论是在J J J APANENSE人类的单一疗法中的单一疗法
2. Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial [J] . Kaku Kohei, Yamada Yuichiro, Watada Hirotaka, Diabetes, obesity & metabolism . 2018,第5期

机译：每周半蛋白质的安全性和有效性与日本人的额外口腔抗糖尿病药物患有2型糖尿病（2型糖尿病）：随机试验
3. Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy [J] . Goldenberg Ronald, Gantz Ira, Andryuk Paula J., Diabetes, obesity & metabolism . 2017,第3期

机译：随机化临床试验比较治疗的疗效和安全性与曾经每周的二肽肽肽酶-4（DPP-4）抑制剂Omarigliptin或患有2型糖尿病患者的一次每日DPP-4抑制剂SitaGlitin在二甲双胍单疗法上不充分控制
4. Testing tailored weekly feedback messages for behavioral change of people living with diabetes using a mHealth application [C] . Noor Al-Ansari, Dena Al-Thani, Luis Fernandez Luque, International Conference on Behavioural and Social Computing . 2020

机译：使用MHECHEATION使用MHECHEATION测试与糖尿病患者患有糖尿病的人行为的每周反馈消息
5. The Effect of Diabetes Self-Management Education (DSME) Through Weekly Text Messages in Adults with Type 2 Diabetes Mellitus [D] . Nnanna, Adaora U. 2020

机译：糖尿病自我管理教育（DSME）对成人型糖尿病型糖尿病的每周短信的影响
6. Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial [O] . Kohei Kaku, Yuichiro Yamada, Hirotaka Watada, -1

机译：随机对照试验：每周一次的司马鲁肽与其他口服抗糖尿病药的安全性和有效性在日本2型糖尿病控制不足的人群中
7. Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial [O] . Kohei Kaku, Yuichiro Yamada, Hirotaka Watada, 2018

机译：每周半蛋白质的安全性和疗效与日本人患有2型糖尿病（2型糖尿病）的额外口腔抗糖尿病药物：随机试验

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily both as monotherapy in Japanese people with type 2 diabetes

摘要

著录项

相似文献

相关主题

期刊订阅